12 Nov 2020
Ionis’ pioneering antisense technology to be featured in multiple presentations at American Heart Association (AHA) Scientific Sessions 2020
Author: admintech | Filed under: Press ReleaseCARLSBAD, Calif., Nov. 12, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), announced today the upcoming presentations of clinical and non-clinical data for several of its investigational antisense medicines for cardiovascular disease at the American Heart Association…